These initiatives are designed to encourage drug companies to develop potent STD drugs.
An industry research report provides a competitive look at the market by type – bacterial infections, viral infections, etc.) and location (North America, Europe, Asia and ROW).
The STD treatment market is extremely competitive with several well-known vendors – GlaxoSmithKline, PLC, Bristol-Meyers Squibb Company, Merck & Co, Inc., Johnson & Johnson Services, Inc. and Gilead Sciences, Inc. – all of them competing for the market based on its presence, quality and price.
A Technavio senior analyst said the STD treatment market has seen a plethora of advances in the diagnostic technology arena. POC testing is quickly making it possible for providers and patients to get what they need since it’s replacing traditional laboratory testing. The market has also seen some major advancements in molecular diagnostics, which will make it easier to get STD treatments – leading to the market’s growth.
The company is highly involved in the finding, development, certifying, engineering, dispensing, marketing and sale of groundbreaking medicines to treat serious diseases. The company’s STDs medicines are Baraclude, Reyataz and Sustiva.
This company is intent on finding, developing and making state-of-the-art medicines in places where medical needs are not being met. Gilead has developed several common STD medications such as Atripla, Biktarvy, Descovy, Gonvoya, Odefsey, Stribild, Symtuza, Truvada and Viread.
This company has its hands in many areas of the healthcare industry such as consumer healthcare, vaccines and pharmaceuticals. Some of its many drugs offered for sexually transmitted disease treatments include Cervarix, Fendrix, Juluca, Selzentry, Trivicay and Triumeg.
One of the world’s most recognized company has its fingers in all kinds of healthcare needs – consumer needs, medical devices and pharmaceutical. It offers the following drugs for STD treatment – Edurant, Intelence, Prezista, Rezolsta and Symtuza.
Another highly-recognizable name in the industry has reached into many segments such as pharmaceutical, health, healthcare services, etc. Some of the STD drugs it offers include Gardasil, Isentress, Recombivax HB.
Written by Mark Riegel, MD
Here’s what we've been up to recently.